ASEP Medical Holdings Inc Registered Shs WKN: A41748 ISIN: CA04368A2048 Kürzel: JJ80 Forum: Aktien Thema: Hauptdiskussion

https://www.ad-hoc-news.de/boerse/news/ueberblick/asep-medical-aktie-handel-wiederaufgenommen/68423294 ..

2025-12-16 14:53 ET - News Release https://www.stockwatch.com/News/Item/Z-C!ASEP-3766169/C/ASEP ASEP MEDICAL HOLDINGS ANNOUNCES REVOCATION OF FAILURE-TO-FILE CEASE TRADE ORDER ASEP Medical Holdings Inc.'s principal regulator, the British Columbia Securities Commission (BCSC), has issued a revocation order lifting the failure-to-file cease trade order (FFCTO) previously imposed on the company. The FFCTO was originally issued on May 6, 2025, as a result of the company's delay in filing its annual audited financial statements for the fiscal year ended Dec. 31, 2024, along with the accompanying management discussion and analysis and related certifications within the prescribed time period under applicable securities regulations. During the period in which the FFCTO was in effect, the company continued to operate its core business activities; however, trading in the company's securities was temporarily restricted. The revocation restores normal trading activity. ASEP Medical remains committed to maintaining strong corporate governance practices and timely financial reporting. With the FFCTO now revoked pursuant to National Policy 11-207, Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions, the company will continue to advance its strategic initiatives, including the further development and commercialization of its sepsis diagnostic (SepsetER) and anti-biofilm peptide technology platforms. The company appreciates the patience and continued support of its shareholders and stakeholders throughout this process. ..

Gibt es Neuigkeiten wann der Handel wieder regulär stattfindet? Muss ggf. noch meinen Verlusttopf füllen.

December 11, 2025 Asep Medical Holdings Amends and Refiles its Management’s Discussion & Analysis for its Year Ended December 31, 2024 https://asepmedical.com/wp-content/uploads/2025/12/Asep-NR-Amended-MDA-12112025.pdf Eine gute Übersicht der Projekte, Patente und Partnerschaften im aktuellen SEDAR Filling https://thecse.com/listings/asep-medical-holdings-inc/sedar-filings/

Müst nur nachschauen was für Luftpumpen er hoch jubelt!

Börsiator schreibt in Wallstreet onlinet unter 19mini99 genau das gleiche wie hier..Börsiator ist mittlerweile schon bekannt dafür.🤣

Der für den 03.12 angekündigte Bericht wurde bereits heute nach Börsenschluss veröffentlicht ASEP Medical Holdings Inc. just filed two new SEDAR documents: Interim financial statements/report https://ceo.ca/content/sedar/ASEP-2025-11-28-interim-financial-statementsreport-english-de9b.pdf Interim MD&A https://ceo.ca/content/sedar/ASEP-2025-11-28-interim-mda-english-a87b.pdf Übersicht aller SEDAR Fillings https://thecse.com/listings/asep-medical-holdings-inc/sedar-filings/

Aus dem aktuellen Monatsbericht von ASEP, CSE-filling November, link: https://thecse.com/listings/asep-medical-holdings-inc/cse-filings/ geht hervor, dass die Wiedereinsetzung in den Handel beantragt wurde Zitat: ..On May 6, 2025, the British Columbia Securities Commission (BCSC), the Issuer’s principal regulator, issued a Failure-to-File Cease Trade Order (FFCTO) against Asep Medical Holdings Inc. for not filing th e audited annual financial statements for the year ended December 31, 2024, the related MD&A, and the CEO/CFO certifications. The Issuer filed these documents on SEDAR+ on October 17, 2025. Because the FFCTO has been in effect for more than 90 days, the Issuer filed an NP 11-207 revocation application with the BCSC on October 28, 2025. No administrative penalty was imposed. As of the date of this form, the FFCTO remains in effect pending the BCSC’s decision.

https://asepmedical.com/wp-content/uploads/2025/11/Asep-NR_Bondent-agreement_Murphy-_1110025_FINAL.pdf November 10, 2025 Asep Medical Holdings Licenses its Anti-Biofilm Technology to Bondent Group for Oral Rinse Development and Commercialization in China Das zweite Standbein neben dem Sepsmart SepsetER Test im JV mit Sansure ist da

News vom Sansure, die ggf auch einmal Auswirkungen auf deren JV Partner  ASEP entfalten könnten: Sansure Biotech to Set Up Medical Tech Partnership Fund Sansure Biotech plans to establish with other investors a partnership fund that will invest in medical devices and biopharmaceuticals, according to a Shanghai bourse filing on Wednesday.The fund,... https://www.marketscreener.com/news/sansure-biotech-to-set-up-medical-tech-partnership-fund-ce7d5ddadf89f420?utm_source=email&utm_medium=social&utm_campaign=share

Aktueller Artikel zum SepsetER Test von ASEP :Game Changer: Kanadische Wissenschaftler entwickeln Bluttest, um das Risiko einer Sepsis schnell vorherzusagen&quot" Veröffentlicht. 20. Oktober 2025 https://hospitalnews.com/game-changer-canadian-scientists-develop-blood-test-to-quickly-predict-risk-of-sepsis/

Dann geht es vielleicht ja bald wieder weiter

Heute, 17.10.2025, veröffentlichte ASEP über ein Dutzend SEDAR & CSE fillings, darunter überfällige Finanzberichte, deren Verspätung zum Aussetzen des Handels geführt hatte Abrufbar u.a über den untenstehenden Link, der ASEP Page an der Heimatbörse CSE https://thecse.com/listings/asep-medical-holdings-inc/